 Katerina Kechris
Concepts (499)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 16 | 2024 | 652 | 3.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 20 | 2024 | 1000 | 2.980 |
Why?
| | DNA Methylation | 20 | 2024 | 606 | 2.470 |
Why?
| | Algorithms | 14 | 2025 | 1617 | 2.270 |
Why?
| | Computational Biology | 9 | 2025 | 593 | 2.210 |
Why?
| | Genome-Wide Association Study | 11 | 2024 | 1326 | 2.170 |
Why?
| | Software | 13 | 2024 | 608 | 2.110 |
Why?
| | Gene Expression Profiling | 19 | 2021 | 1686 | 1.870 |
Why?
| | Sequence Analysis, RNA | 9 | 2021 | 426 | 1.830 |
Why?
| | Bayes Theorem | 10 | 2023 | 374 | 1.780 |
Why?
| | Proteomics | 4 | 2025 | 1058 | 1.690 |
Why?
| | MicroRNAs | 10 | 2023 | 680 | 1.690 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2021 | 486 | 1.520 |
Why?
| | Mass Spectrometry | 6 | 2022 | 717 | 1.490 |
Why?
| | Genomics | 7 | 2025 | 716 | 1.480 |
Why?
| | Quantitative Trait Loci | 15 | 2024 | 352 | 1.390 |
Why?
| | Gene Regulatory Networks | 6 | 2025 | 280 | 1.360 |
Why?
| | Data Interpretation, Statistical | 5 | 2020 | 338 | 1.260 |
Why?
| | Prenatal Exposure Delayed Effects | 12 | 2024 | 573 | 1.190 |
Why?
| | Polymorphism, Single Nucleotide | 11 | 2024 | 2062 | 1.180 |
Why?
| | Gene Expression Regulation | 12 | 2022 | 2545 | 1.150 |
Why?
| | Models, Genetic | 7 | 2019 | 592 | 1.100 |
Why?
| | Smoking | 8 | 2024 | 1502 | 1.080 |
Why?
| | Phenotype | 21 | 2024 | 3062 | 1.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2021 | 756 | 0.940 |
Why?
| | Adiposity | 10 | 2024 | 504 | 0.920 |
Why?
| | Brain | 9 | 2024 | 2677 | 0.870 |
Why?
| | Gene Expression | 10 | 2021 | 1465 | 0.860 |
Why?
| | Transcriptome | 9 | 2021 | 875 | 0.820 |
Why?
| | Metabolome | 5 | 2024 | 339 | 0.800 |
Why?
| | Databases, Factual | 6 | 2021 | 1269 | 0.780 |
Why?
| | Computer Simulation | 9 | 2025 | 941 | 0.780 |
Why?
| | Models, Statistical | 5 | 2020 | 624 | 0.740 |
Why?
| | Emphysema | 4 | 2023 | 109 | 0.740 |
Why?
| | Propensity Score | 1 | 2023 | 266 | 0.730 |
Why?
| | Ethanol | 5 | 2020 | 591 | 0.690 |
Why?
| | Maternal Exposure | 6 | 2024 | 177 | 0.680 |
Why?
| | Machine Learning | 2 | 2024 | 441 | 0.680 |
Why?
| | Pediatric Obesity | 7 | 2024 | 573 | 0.670 |
Why?
| | Conserved Sequence | 3 | 2009 | 227 | 0.660 |
Why?
| | Islets of Langerhans | 6 | 2024 | 791 | 0.650 |
Why?
| | Humans | 95 | 2025 | 129847 | 0.640 |
Why?
| | Pulmonary Emphysema | 6 | 2023 | 275 | 0.640 |
Why?
| | User-Computer Interface | 1 | 2020 | 149 | 0.640 |
Why?
| | Epigenesis, Genetic | 12 | 2024 | 615 | 0.630 |
Why?
| | RNA | 4 | 2021 | 877 | 0.610 |
Why?
| | Biomarkers | 19 | 2024 | 3971 | 0.600 |
Why?
| | Fluorocarbons | 4 | 2023 | 109 | 0.600 |
Why?
| | Diabetes Mellitus, Type 1 | 11 | 2024 | 3630 | 0.590 |
Why?
| | Health Status | 1 | 2023 | 758 | 0.570 |
Why?
| | Fetal Blood | 10 | 2024 | 318 | 0.560 |
Why?
| | Autoimmunity | 8 | 2024 | 863 | 0.530 |
Why?
| | ROC Curve | 5 | 2020 | 504 | 0.530 |
Why?
| | Linear Models | 4 | 2019 | 822 | 0.530 |
Why?
| | Hypnotics and Sedatives | 1 | 2018 | 178 | 0.510 |
Why?
| | Genetic Predisposition to Disease | 11 | 2023 | 2271 | 0.500 |
Why?
| | Models, Theoretical | 1 | 2020 | 549 | 0.500 |
Why?
| | Alcoholism | 3 | 2020 | 766 | 0.500 |
Why?
| | Animals | 34 | 2023 | 35409 | 0.500 |
Why?
| | Female | 62 | 2024 | 68829 | 0.500 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.470 |
Why?
| | Drosophila | 3 | 2010 | 141 | 0.460 |
Why?
| | CpG Islands | 7 | 2024 | 152 | 0.450 |
Why?
| | Environmental Pollutants | 3 | 2023 | 143 | 0.450 |
Why?
| | Placenta | 5 | 2023 | 716 | 0.450 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.430 |
Why?
| | Case-Control Studies | 14 | 2023 | 3384 | 0.430 |
Why?
| | Nitrogenase | 2 | 2013 | 9 | 0.430 |
Why?
| | Pregnancy | 21 | 2024 | 6423 | 0.420 |
Why?
| | Mice | 19 | 2022 | 16983 | 0.410 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1416 | 0.410 |
Why?
| | Smoking Cessation | 1 | 2017 | 409 | 0.410 |
Why?
| | Schistosomiasis japonica | 3 | 2022 | 32 | 0.410 |
Why?
| | Markov Chains | 2 | 2020 | 117 | 0.400 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1501 | 0.400 |
Why?
| | RNA, Messenger | 7 | 2023 | 2703 | 0.400 |
Why?
| | DNA | 3 | 2019 | 1406 | 0.390 |
Why?
| | Sample Size | 3 | 2023 | 116 | 0.390 |
Why?
| | Genotype | 6 | 2020 | 1829 | 0.380 |
Why?
| | Male | 48 | 2024 | 63759 | 0.380 |
Why?
| | Transcription Factors | 6 | 2024 | 1645 | 0.380 |
Why?
| | Diabetes, Gestational | 3 | 2023 | 308 | 0.380 |
Why?
| | Phylogeny | 2 | 2013 | 845 | 0.380 |
Why?
| | Lipid Metabolism | 4 | 2024 | 503 | 0.370 |
Why?
| | Schistosoma japonicum | 2 | 2022 | 31 | 0.360 |
Why?
| | Support Vector Machine | 2 | 2021 | 38 | 0.350 |
Why?
| | Lung | 5 | 2023 | 3940 | 0.350 |
Why?
| | Bias | 2 | 2022 | 197 | 0.340 |
Why?
| | Area Under Curve | 3 | 2020 | 306 | 0.340 |
Why?
| | Genome, Human | 3 | 2019 | 393 | 0.330 |
Why?
| | Binding Sites | 5 | 2021 | 1251 | 0.320 |
Why?
| | Child | 27 | 2024 | 20962 | 0.320 |
Why?
| | Molybdoferredoxin | 1 | 2009 | 12 | 0.320 |
Why?
| | Gastrointestinal Tract | 2 | 2022 | 187 | 0.310 |
Why?
| | Oxidoreductases | 1 | 2009 | 92 | 0.300 |
Why?
| | Infant, Newborn | 15 | 2024 | 5772 | 0.300 |
Why?
| | Insulin | 6 | 2023 | 2330 | 0.300 |
Why?
| | Child, Preschool | 17 | 2024 | 10522 | 0.300 |
Why?
| | Mycobacterium tuberculosis | 3 | 2016 | 309 | 0.290 |
Why?
| | Adiponectin | 2 | 2024 | 236 | 0.290 |
Why?
| | Signal Transduction | 7 | 2020 | 4935 | 0.290 |
Why?
| | Disease Progression | 5 | 2024 | 2628 | 0.280 |
Why?
| | Exons | 1 | 2008 | 341 | 0.280 |
Why?
| | Autoantibodies | 4 | 2024 | 1468 | 0.280 |
Why?
| | HIV-1 | 3 | 2022 | 839 | 0.270 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2022 | 646 | 0.270 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2021 | 310 | 0.270 |
Why?
| | Leukocytes, Mononuclear | 3 | 2015 | 546 | 0.270 |
Why?
| | Cluster Analysis | 3 | 2024 | 483 | 0.260 |
Why?
| | Alternative Splicing | 1 | 2008 | 216 | 0.260 |
Why?
| | Cohort Studies | 10 | 2023 | 5444 | 0.260 |
Why?
| | Alcohol Drinking | 5 | 2014 | 764 | 0.260 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 191 | 0.250 |
Why?
| | Environmental Exposure | 2 | 2020 | 463 | 0.250 |
Why?
| | HIV Infections | 4 | 2022 | 2730 | 0.250 |
Why?
| | Middle Aged | 18 | 2024 | 31177 | 0.240 |
Why?
| | Genome | 3 | 2013 | 278 | 0.240 |
Why?
| | Alkanesulfonic Acids | 2 | 2023 | 34 | 0.240 |
Why?
| | Tuberculosis | 2 | 2020 | 273 | 0.230 |
Why?
| | Principal Component Analysis | 2 | 2023 | 190 | 0.230 |
Why?
| | Oxylipins | 2 | 2023 | 33 | 0.230 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 135 | 0.230 |
Why?
| | Soot | 1 | 2024 | 25 | 0.230 |
Why?
| | Aged | 13 | 2024 | 22107 | 0.230 |
Why?
| | Mice, Inbred Strains | 4 | 2020 | 408 | 0.230 |
Why?
| | Prospective Studies | 9 | 2023 | 7158 | 0.220 |
Why?
| | Quantitative Trait, Heritable | 3 | 2017 | 121 | 0.220 |
Why?
| | Seroconversion | 2 | 2021 | 46 | 0.220 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 45 | 0.220 |
Why?
| | Melanocytes | 2 | 2015 | 65 | 0.220 |
Why?
| | Body Mass Index | 5 | 2024 | 2274 | 0.210 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3089 | 0.210 |
Why?
| | Mice, Inbred C57BL | 5 | 2019 | 5468 | 0.210 |
Why?
| | Severity of Illness Index | 5 | 2021 | 2739 | 0.210 |
Why?
| | Infant | 12 | 2024 | 9018 | 0.210 |
Why?
| | Diet | 2 | 2021 | 1212 | 0.210 |
Why?
| | Sequence Analysis, DNA | 2 | 2019 | 778 | 0.210 |
Why?
| | Genetic Association Studies | 3 | 2020 | 357 | 0.200 |
Why?
| | Genetic Variation | 3 | 2024 | 937 | 0.200 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 129 | 0.200 |
Why?
| | Phospholipids | 2 | 2021 | 216 | 0.200 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.200 |
Why?
| | Birth Weight | 3 | 2023 | 505 | 0.200 |
Why?
| | Mothers | 3 | 2023 | 731 | 0.190 |
Why?
| | Breast Neoplasms | 3 | 2019 | 2104 | 0.190 |
Why?
| | Air Pollutants | 2 | 2024 | 314 | 0.190 |
Why?
| | Schistosomiasis | 1 | 2022 | 47 | 0.190 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 64 | 0.180 |
Why?
| | Selection Bias | 1 | 2021 | 37 | 0.180 |
Why?
| | Endemic Diseases | 1 | 2021 | 31 | 0.180 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 61 | 0.180 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2021 | 31 | 0.180 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1847 | 0.180 |
Why?
| | Cloud Computing | 1 | 2021 | 7 | 0.180 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.180 |
Why?
| | Adult | 20 | 2024 | 35634 | 0.180 |
Why?
| | Immunoglobulin A | 1 | 2022 | 201 | 0.180 |
Why?
| | Central Nervous System Depressants | 2 | 2012 | 83 | 0.180 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 41 | 0.180 |
Why?
| | Genome, Viral | 1 | 2021 | 128 | 0.180 |
Why?
| | Mutation | 3 | 2021 | 3706 | 0.180 |
Why?
| | Normal Distribution | 2 | 2018 | 21 | 0.170 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 106 | 0.170 |
Why?
| | Polyadenylation | 1 | 2021 | 40 | 0.170 |
Why?
| | Population Dynamics | 1 | 2021 | 138 | 0.170 |
Why?
| | Biostatistics | 1 | 2020 | 16 | 0.170 |
Why?
| | Travel | 1 | 2021 | 122 | 0.170 |
Why?
| | Probability | 1 | 2021 | 304 | 0.170 |
Why?
| | Drug Tolerance | 1 | 2020 | 90 | 0.170 |
Why?
| | Interferon-beta | 1 | 2020 | 89 | 0.170 |
Why?
| | Monte Carlo Method | 1 | 2020 | 143 | 0.170 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 128 | 0.170 |
Why?
| | Discriminant Analysis | 1 | 2020 | 39 | 0.170 |
Why?
| | Risk Factors | 8 | 2024 | 9801 | 0.160 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 137 | 0.160 |
Why?
| | Premature Birth | 1 | 2023 | 317 | 0.160 |
Why?
| | Smoke | 2 | 2023 | 140 | 0.160 |
Why?
| | Least-Squares Analysis | 1 | 2020 | 79 | 0.160 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2020 | 190 | 0.160 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 277 | 0.160 |
Why?
| | Decision Trees | 1 | 2020 | 90 | 0.160 |
Why?
| | Liver | 2 | 2019 | 1839 | 0.160 |
Why?
| | Air Pollution | 1 | 2022 | 218 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2020 | 194 | 0.160 |
Why?
| | Sex Characteristics | 2 | 2023 | 735 | 0.160 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.160 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 104 | 0.150 |
Why?
| | Atherosclerosis | 1 | 2023 | 402 | 0.150 |
Why?
| | Rats | 4 | 2023 | 5487 | 0.150 |
Why?
| | Adolescent | 10 | 2024 | 20451 | 0.150 |
Why?
| | Proteome | 1 | 2023 | 440 | 0.150 |
Why?
| | Base Sequence | 3 | 2021 | 2142 | 0.150 |
Why?
| | Marijuana Use | 1 | 2022 | 192 | 0.150 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2019 | 67 | 0.150 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 17 | 0.150 |
Why?
| | Reflex, Righting | 1 | 2018 | 11 | 0.150 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 386 | 0.150 |
Why?
| | Antiviral Agents | 2 | 2021 | 719 | 0.150 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 310 | 0.140 |
Why?
| | Receptor, Insulin | 1 | 2017 | 99 | 0.140 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2017 | 11 | 0.140 |
Why?
| | Rural Population | 1 | 2021 | 521 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 260 | 0.140 |
Why?
| | Dendritic Cells | 1 | 2020 | 481 | 0.140 |
Why?
| | Receptors, GABA-A | 1 | 2018 | 125 | 0.140 |
Why?
| | Alcohol-Related Disorders | 1 | 2018 | 118 | 0.130 |
Why?
| | Epigenomics | 2 | 2018 | 110 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 631 | 0.130 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 392 | 0.130 |
Why?
| | Otitis Media | 1 | 2019 | 160 | 0.130 |
Why?
| | Alleles | 1 | 2019 | 843 | 0.130 |
Why?
| | Chemokines | 1 | 2017 | 227 | 0.130 |
Why?
| | Longitudinal Studies | 5 | 2024 | 2724 | 0.130 |
Why?
| | Longevity | 1 | 2017 | 155 | 0.130 |
Why?
| | Biomedical Research | 2 | 2020 | 640 | 0.130 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 210 | 0.130 |
Why?
| | Predictive Value of Tests | 3 | 2017 | 1951 | 0.130 |
Why?
| | DNA-Binding Proteins | 3 | 2019 | 1441 | 0.130 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 185 | 0.130 |
Why?
| | Age Factors | 2 | 2021 | 3161 | 0.120 |
Why?
| | Keratinocytes | 1 | 2017 | 244 | 0.120 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2017 | 200 | 0.120 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 8 | 0.120 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 185 | 0.120 |
Why?
| | Corpus Luteum | 1 | 2015 | 20 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 206 | 0.120 |
Why?
| | Databases, Genetic | 2 | 2021 | 228 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 68 | 0.120 |
Why?
| | Adaptation, Physiological | 2 | 2016 | 521 | 0.120 |
Why?
| | Granulosa Cells | 1 | 2015 | 33 | 0.120 |
Why?
| | Tobacco Products | 1 | 2016 | 110 | 0.120 |
Why?
| | Ultraviolet Therapy | 1 | 2015 | 16 | 0.120 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.120 |
Why?
| | Sphingomyelins | 1 | 2015 | 29 | 0.120 |
Why?
| | Infant, Premature | 1 | 2019 | 541 | 0.120 |
Why?
| | Obesity | 4 | 2023 | 2885 | 0.120 |
Why?
| | Aged, 80 and over | 8 | 2021 | 7066 | 0.120 |
Why?
| | Vitiligo | 1 | 2015 | 41 | 0.120 |
Why?
| | Cannabis | 1 | 2022 | 462 | 0.120 |
Why?
| | Microarray Analysis | 2 | 2012 | 113 | 0.120 |
Why?
| | Child Development | 1 | 2019 | 459 | 0.110 |
Why?
| | Hair | 1 | 2015 | 73 | 0.110 |
Why?
| | Databases, Nucleic Acid | 1 | 2014 | 33 | 0.110 |
Why?
| | Blood Proteins | 1 | 2016 | 245 | 0.110 |
Why?
| | Fatty Acids | 1 | 2017 | 427 | 0.110 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 231 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2833 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 641 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2020 | 1063 | 0.110 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 175 | 0.110 |
Why?
| | STAT2 Transcription Factor | 1 | 2013 | 3 | 0.110 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 138 | 0.110 |
Why?
| | CCCTC-Binding Factor | 1 | 2013 | 14 | 0.110 |
Why?
| | Gangliosides | 1 | 2013 | 19 | 0.110 |
Why?
| | Caloric Restriction | 1 | 2015 | 111 | 0.110 |
Why?
| | Species Specificity | 2 | 2012 | 568 | 0.110 |
Why?
| | Saccharomyces | 1 | 2013 | 8 | 0.110 |
Why?
| | Dietary Fats | 1 | 2015 | 303 | 0.110 |
Why?
| | G-Quadruplexes | 1 | 2013 | 17 | 0.100 |
Why?
| | Myocardium | 1 | 2018 | 983 | 0.100 |
Why?
| | Antitubercular Agents | 1 | 2015 | 200 | 0.100 |
Why?
| | Choice Behavior | 1 | 2014 | 167 | 0.100 |
Why?
| | Microbiota | 1 | 2021 | 734 | 0.100 |
Why?
| | Sequence Alignment | 1 | 2013 | 331 | 0.100 |
Why?
| | DNA Probes | 1 | 2012 | 60 | 0.100 |
Why?
| | Programming Languages | 1 | 2012 | 23 | 0.100 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2015 | 324 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 136 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1327 | 0.100 |
Why?
| | Teratogens | 1 | 2012 | 9 | 0.100 |
Why?
| | Tretinoin | 1 | 2013 | 121 | 0.100 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 383 | 0.100 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1199 | 0.100 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2012 | 29 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 3 | 2021 | 2511 | 0.090 |
Why?
| | Weight Gain | 1 | 2015 | 510 | 0.090 |
Why?
| | Protein Binding | 2 | 2021 | 2123 | 0.090 |
Why?
| | China | 2 | 2022 | 192 | 0.090 |
Why?
| | Regression Analysis | 3 | 2021 | 998 | 0.090 |
Why?
| | Triglycerides | 2 | 2023 | 528 | 0.090 |
Why?
| | Chromosome Mapping | 3 | 2020 | 499 | 0.090 |
Why?
| | Stem Cells | 1 | 2015 | 578 | 0.090 |
Why?
| | Body Weight | 1 | 2015 | 947 | 0.090 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 78 | 0.090 |
Why?
| | Dysbiosis | 2 | 2022 | 170 | 0.090 |
Why?
| | Pain Threshold | 1 | 2010 | 79 | 0.090 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 80 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2012 | 820 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2013 | 404 | 0.080 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 532 | 0.080 |
Why?
| | Young Adult | 7 | 2020 | 12467 | 0.080 |
Why?
| | Asthma | 1 | 2023 | 2225 | 0.080 |
Why?
| | Morphine | 1 | 2010 | 139 | 0.080 |
Why?
| | Cytokines | 1 | 2017 | 2022 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2057 | 0.080 |
Why?
| | Internet | 2 | 2010 | 620 | 0.080 |
Why?
| | Hedgehog Proteins | 1 | 2010 | 188 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2012 | 1291 | 0.080 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1033 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2015 | 875 | 0.080 |
Why?
| | Vital Capacity | 2 | 2021 | 290 | 0.080 |
Why?
| | Drosophila Proteins | 1 | 2010 | 187 | 0.080 |
Why?
| | Yeasts | 1 | 2008 | 52 | 0.080 |
Why?
| | Spirometry | 2 | 2021 | 257 | 0.080 |
Why?
| | Synaptic Transmission | 1 | 2010 | 275 | 0.070 |
Why?
| | Fasting | 2 | 2023 | 268 | 0.070 |
Why?
| | Food Preferences | 1 | 2009 | 116 | 0.070 |
Why?
| | Gestational Age | 2 | 2023 | 876 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 34 | 0.070 |
Why?
| | Forced Expiratory Volume | 2 | 2021 | 508 | 0.070 |
Why?
| | RNA Precursors | 1 | 2008 | 148 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 177 | 0.070 |
Why?
| | Folic Acid | 2 | 2019 | 182 | 0.070 |
Why?
| | Gene Ontology | 2 | 2017 | 49 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 2 | 2021 | 528 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4896 | 0.060 |
Why?
| | Phosphorylation | 2 | 2021 | 1716 | 0.060 |
Why?
| | Neoplasms | 2 | 2018 | 2454 | 0.060 |
Why?
| | Uganda | 2 | 2016 | 70 | 0.060 |
Why?
| | Glucose | 2 | 2023 | 1003 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2489 | 0.060 |
Why?
| | Sputum | 2 | 2016 | 302 | 0.050 |
Why?
| | Alkanesulfonates | 1 | 2023 | 7 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| | Carboxylic Acids | 1 | 2023 | 33 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 51 | 0.050 |
Why?
| | Privacy | 1 | 2023 | 33 | 0.050 |
Why?
| | Hypertrophy | 1 | 2023 | 125 | 0.050 |
Why?
| | Cell Proliferation | 3 | 2015 | 2378 | 0.050 |
Why?
| | Analgesics, Opioid | 1 | 2010 | 925 | 0.050 |
Why?
| | Models, Neurological | 1 | 2024 | 240 | 0.050 |
Why?
| | Pneumonia | 2 | 2020 | 619 | 0.050 |
Why?
| | Schistosoma | 1 | 2022 | 28 | 0.050 |
Why?
| | Snails | 1 | 2022 | 34 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2023 | 1900 | 0.050 |
Why?
| | Pregnant Women | 1 | 2023 | 114 | 0.050 |
Why?
| | Benchmarking | 1 | 2023 | 176 | 0.050 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2021 | 15 | 0.050 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2021 | 15 | 0.050 |
Why?
| | Furin | 1 | 2021 | 14 | 0.050 |
Why?
| | Asia | 1 | 2021 | 58 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 205 | 0.050 |
Why?
| | Nerve Net | 1 | 2024 | 260 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 47 | 0.050 |
Why?
| | Africa | 1 | 2021 | 99 | 0.050 |
Why?
| | Water Resources | 1 | 2021 | 8 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 118 | 0.050 |
Why?
| | Epidemiological Monitoring | 1 | 2021 | 50 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 109 | 0.050 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 63 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 412 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 63 | 0.040 |
Why?
| | Alanine | 1 | 2021 | 143 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 115 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 139 | 0.040 |
Why?
| | Europe | 1 | 2021 | 363 | 0.040 |
Why?
| | Sex Factors | 2 | 2019 | 1973 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 284 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 166 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 82 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 60 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 437 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 46 | 0.040 |
Why?
| | Particulate Matter | 1 | 2022 | 247 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 109 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 157 | 0.040 |
Why?
| | Swine | 1 | 2022 | 761 | 0.040 |
Why?
| | Colon | 1 | 2022 | 257 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 569 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 101 | 0.040 |
Why?
| | Cattle | 1 | 2022 | 978 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 49 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 75 | 0.040 |
Why?
| | Finland | 1 | 2019 | 90 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 219 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1092 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5085 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 585 | 0.040 |
Why?
| | Water | 1 | 2022 | 442 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 91 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 494 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 500 | 0.040 |
Why?
| | Computer Graphics | 1 | 2018 | 41 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2019 | 233 | 0.040 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 160 | 0.040 |
Why?
| | Leptin | 1 | 2019 | 222 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 241 | 0.040 |
Why?
| | Environmental Pollution | 1 | 2018 | 19 | 0.040 |
Why?
| | Pedigree | 1 | 2019 | 483 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 44 | 0.040 |
Why?
| | United States | 3 | 2021 | 13913 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 424 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2021 | 462 | 0.040 |
Why?
| | Maternal Health | 1 | 2018 | 45 | 0.040 |
Why?
| | Collagen | 1 | 2020 | 438 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2017 | 25 | 0.030 |
Why?
| | Caprylates | 1 | 2017 | 22 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 70 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 398 | 0.030 |
Why?
| | Time Factors | 2 | 2021 | 6550 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2017 | 83 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 417 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 108 | 0.030 |
Why?
| | Gambia | 1 | 2016 | 14 | 0.030 |
Why?
| | THP-1 Cells | 1 | 2016 | 22 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2016 | 44 | 0.030 |
Why?
| | Lod Score | 1 | 2016 | 66 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 804 | 0.030 |
Why?
| | Regulon | 1 | 2016 | 35 | 0.030 |
Why?
| | ABO Blood-Group System | 1 | 2016 | 39 | 0.030 |
Why?
| | Actins | 1 | 2018 | 410 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2016 | 52 | 0.030 |
Why?
| | Antigen Presentation | 1 | 2017 | 207 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 1989 | 0.030 |
Why?
| | Child Health | 1 | 2018 | 147 | 0.030 |
Why?
| | Fetal Development | 1 | 2019 | 287 | 0.030 |
Why?
| | Granuloma | 1 | 2016 | 90 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1168 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 257 | 0.030 |
Why?
| | Follicular Phase | 1 | 2015 | 38 | 0.030 |
Why?
| | Ovulation | 1 | 2015 | 40 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2022 | 1058 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2564 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 11 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 814 | 0.030 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2017 | 194 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 88 | 0.030 |
Why?
| | Mice, Congenic | 1 | 2015 | 22 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 40 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 308 | 0.030 |
Why?
| | Hair Follicle | 1 | 2015 | 45 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 68 | 0.030 |
Why?
| | Immune System | 1 | 2016 | 175 | 0.030 |
Why?
| | Latent Tuberculosis | 1 | 2015 | 67 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 63 | 0.030 |
Why?
| | Heart | 1 | 2018 | 645 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 554 | 0.030 |
Why?
| | Breeding | 1 | 2014 | 61 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 782 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2017 | 232 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 296 | 0.030 |
Why?
| | Protein Kinases | 1 | 2016 | 318 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 155 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2015 | 239 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1031 | 0.030 |
Why?
| | Monophenol Monooxygenase | 1 | 2013 | 8 | 0.030 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2013 | 17 | 0.030 |
Why?
| | Annexin A5 | 1 | 2013 | 23 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1597 | 0.030 |
Why?
| | Melanins | 1 | 2013 | 18 | 0.030 |
Why?
| | Spectrophotometry | 1 | 2013 | 58 | 0.030 |
Why?
| | Education | 1 | 2013 | 104 | 0.030 |
Why?
| | Catalase | 1 | 2013 | 128 | 0.030 |
Why?
| | Blood Glucose | 1 | 2023 | 2103 | 0.030 |
Why?
| | Administration, Topical | 1 | 2013 | 147 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 371 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1213 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 422 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 329 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 549 | 0.020 |
Why?
| | Neutrophils | 1 | 2017 | 1209 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 610 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2014 | 226 | 0.020 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2010 | 11 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1119 | 0.020 |
Why?
| | Receptors, GABA | 1 | 2010 | 11 | 0.020 |
Why?
| | Thermosensing | 1 | 2010 | 11 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 342 | 0.020 |
Why?
| | Software Design | 1 | 2010 | 23 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 40 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2010 | 134 | 0.020 |
Why?
| | Cell Movement | 1 | 2015 | 950 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2016 | 838 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 167 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 902 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4410 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 295 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1086 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1724 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2010 | 168 | 0.020 |
Why?
| | Antioxidants | 1 | 2013 | 558 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2009 | 368 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2009 | 118 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1087 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 1489 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1488 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2444 | 0.020 |
Why?
| | Histones | 1 | 2013 | 588 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5437 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 928 | 0.020 |
Why?
| | Brain Mapping | 1 | 2010 | 575 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3185 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 4102 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2045 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 14553 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4077 | 0.010 |
Why?
|
|
Kechris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|